Verdezyne Receives Federal Grant to Advance Synthetic Biology Tools
19 October 2009
Verdezyne, Inc., a privately-held synthetic biology company developing fermentation processes for industrial chemicals and biofuels, has been awarded a $1.7 million grant from the National Institute of Allergy And Infectious Diseases (NIAID) for a period of 1.5 years. The goal of this program is to quickly and reliably advance the construction of directed mutant gene libraries widely considered important technology tools for synthetic biology.
Verdezyne will apply their proprietary computational and bioinformatics programs to create highly diverse gene libraries to further enhance metabolic engineering tools. This enhanced capability will be directly useful to life science researchers, and serve as a platform for protein and metabolic engineering.
This grant will fund research to progress the role of bioinformatics in synthetic biology. By advancing this technology, we will be able to utilize the computational tools for improved protein expression and function for our internal biofuel and bio-based chemical programs.
—Stephen Picataggio, Ph.D., Chief Scientific Officer, Verdezyne
The project described was supported by STTR program with Award Number 2R42A1066758 from the National Institute of Allergy And Infectious Diseases.
Avoid the rush.
Posted by: arnold | 19 October 2009 at 04:58 PM